vs
Side-by-side financial comparison of Dole plc (DOLE) and Incyte (INCY). Click either name above to swap in a different company.
Dole plc is the larger business by last-quarter revenue ($2.3B vs $1.3B, roughly 1.8× Incyte). Incyte runs the higher net margin — 23.8% vs 0.2%, a 23.6% gap on every dollar of revenue. On growth, Incyte posted the faster year-over-year revenue change (19.8% vs 10.5%). Over the past eight quarters, Incyte's revenue compounded faster (10.4% CAGR vs 3.2%).
Dole plc is an Irish-American agricultural multinational corporation headquartered in Dublin, Ireland. The company is among the world's largest producers of fruit and vegetables, operating with 38,500 full-time and seasonal employees who supply some 300 products in 75 countries. Dole reported 2021 revenues of $6.5 billion.
Incyte Corporation is an American multinational pharmaceutical company with headquarters in Wilmington, Delaware. The company currently operates manufacturing and R&D locations in North America, Europe, and Asia.
DOLE vs INCY — Head-to-Head
Income Statement — Q3 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $2.3B | $1.3B |
| Net Profit | $5.1M | $303.3M |
| Gross Margin | 6.8% | — |
| Operating Margin | 1.1% | 23.7% |
| Net Margin | 0.2% | 23.8% |
| Revenue YoY | 10.5% | 19.8% |
| Net Profit YoY | -64.6% | 91.7% |
| EPS (diluted) | $0.05 | $1.47 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $1.3B | ||
| Q4 25 | — | $1.5B | ||
| Q3 25 | $2.3B | $1.4B | ||
| Q2 25 | $2.4B | $1.2B | ||
| Q1 25 | $2.1B | $1.1B | ||
| Q4 24 | — | $1.2B | ||
| Q3 24 | $2.1B | $1.1B | ||
| Q2 24 | $2.1B | $1.0B |
| Q1 26 | — | $303.3M | ||
| Q4 25 | — | $299.3M | ||
| Q3 25 | $5.1M | $424.2M | ||
| Q2 25 | $10.0M | $405.0M | ||
| Q1 25 | $38.9M | $158.2M | ||
| Q4 24 | — | $201.2M | ||
| Q3 24 | $14.4M | $106.5M | ||
| Q2 24 | $80.1M | $-444.6M |
| Q1 26 | — | — | ||
| Q4 25 | — | 92.0% | ||
| Q3 25 | 6.8% | 92.8% | ||
| Q2 25 | 9.0% | 93.5% | ||
| Q1 25 | 8.7% | 93.0% | ||
| Q4 24 | — | 92.5% | ||
| Q3 24 | 8.0% | 92.4% | ||
| Q2 24 | 9.4% | 92.7% |
| Q1 26 | — | 23.7% | ||
| Q4 25 | — | 22.3% | ||
| Q3 25 | 1.1% | 32.5% | ||
| Q2 25 | 4.3% | 43.6% | ||
| Q1 25 | 3.2% | 19.5% | ||
| Q4 24 | — | 25.6% | ||
| Q3 24 | 2.3% | 12.8% | ||
| Q2 24 | 4.0% | -45.8% |
| Q1 26 | — | 23.8% | ||
| Q4 25 | — | 19.9% | ||
| Q3 25 | 0.2% | 31.1% | ||
| Q2 25 | 0.4% | 33.3% | ||
| Q1 25 | 1.9% | 15.0% | ||
| Q4 24 | — | 17.1% | ||
| Q3 24 | 0.7% | 9.4% | ||
| Q2 24 | 3.8% | -42.6% |
| Q1 26 | — | $1.47 | ||
| Q4 25 | — | $1.46 | ||
| Q3 25 | $0.05 | $2.11 | ||
| Q2 25 | $0.10 | $2.04 | ||
| Q1 25 | $0.41 | $0.80 | ||
| Q4 24 | — | $0.90 | ||
| Q3 24 | $0.15 | $0.54 | ||
| Q2 24 | $0.84 | $-2.04 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $321.0M | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $1.4B | $5.6B |
| Total Assets | $4.5B | $7.3B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | — | $3.1B | ||
| Q3 25 | $321.0M | $2.5B | ||
| Q2 25 | $323.1M | $2.0B | ||
| Q1 25 | $261.0M | $1.9B | ||
| Q4 24 | — | $1.7B | ||
| Q3 24 | $266.4M | $1.3B | ||
| Q2 24 | $225.8M | $987.3M |
| Q1 26 | — | $5.6B | ||
| Q4 25 | — | $5.2B | ||
| Q3 25 | $1.4B | $4.7B | ||
| Q2 25 | $1.4B | $4.2B | ||
| Q1 25 | $1.3B | $3.7B | ||
| Q4 24 | — | $3.4B | ||
| Q3 24 | $1.4B | $3.2B | ||
| Q2 24 | $1.4B | $3.0B |
| Q1 26 | — | $7.3B | ||
| Q4 25 | — | $7.0B | ||
| Q3 25 | $4.5B | $6.3B | ||
| Q2 25 | $4.7B | $5.8B | ||
| Q1 25 | $4.5B | $5.7B | ||
| Q4 24 | — | $5.4B | ||
| Q3 24 | $4.5B | $5.0B | ||
| Q2 24 | $4.4B | $4.7B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $87.4M | — |
| Free Cash FlowOCF − Capex | $66.5M | — |
| FCF MarginFCF / Revenue | 2.9% | — |
| Capex IntensityCapex / Revenue | 0.9% | — |
| Cash ConversionOCF / Net Profit | 17.12× | — |
| TTM Free Cash FlowTrailing 4 quarters | $13.7M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | — | $543.3M | ||
| Q3 25 | $87.4M | $559.4M | ||
| Q2 25 | $18.3M | $44.7M | ||
| Q1 25 | $-78.8M | $266.1M | ||
| Q4 24 | — | $381.2M | ||
| Q3 24 | $101.0M | $310.9M | ||
| Q2 24 | $40.2M | $-575.6M |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | $66.5M | — | ||
| Q2 25 | $-1.0M | — | ||
| Q1 25 | $-131.6M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $79.9M | — | ||
| Q2 24 | $22.8M | — |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | 2.9% | — | ||
| Q2 25 | -0.0% | — | ||
| Q1 25 | -6.3% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 3.9% | — | ||
| Q2 24 | 1.1% | — |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | 0.9% | — | ||
| Q2 25 | 0.8% | — | ||
| Q1 25 | 2.5% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 1.0% | — | ||
| Q2 24 | 0.8% | — |
| Q1 26 | — | — | ||
| Q4 25 | — | 1.82× | ||
| Q3 25 | 17.12× | 1.32× | ||
| Q2 25 | 1.84× | 0.11× | ||
| Q1 25 | -2.02× | 1.68× | ||
| Q4 24 | — | 1.89× | ||
| Q3 24 | 7.01× | 2.92× | ||
| Q2 24 | 0.50× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
